In a filing, Emergent Biosolutions Inc revealed its Director Zoon Kathryn C unloaded Company’s shares for reported $8436.0 on May 29 ’24. In the deal valued at $4.61 per share,1,830 shares were sold. As a result of this transaction, Zoon Kathryn C now holds 64,482 shares worth roughly $0.39 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Zoon Kathryn C sold 1,089 shares, generating $6,294 in total proceeds. Upon selling the shares at $5.78, the Director now owns 48,882 shares.
The Benchmark Company upgraded its Emergent Biosolutions Inc [EBS] rating to a Buy from a a Hold in a research note published recently. The Benchmark Company also remained covering EBS and has decreased its forecast on August 29, 2023 with a “Hold” recommendation from previously “Buy” rating. The Benchmark Company revised its rating on April 10, 2023. It rated EBS as “a Buy” which previously was an “a Hold”.
Price Performance Review of EBS
On Monday, Emergent Biosolutions Inc [NYSE:EBS] saw its stock jump 7.19% to $6.11. Over the last five days, the stock has gained 28.36%. Emergent Biosolutions Inc shares have risen nearly 154.58% since the year began. Nevertheless, the stocks have fallen -25.49% over the past one year. While a 52-week high of $9.96 was reached on 05/20/24, a 52-week low of $1.42 was recorded on 02/06/24. SMA at 50 days reached $3.37, while 200 days put it at $2.85. A total of 2.4 million shares were traded, compared to the trading of 2.47 million shares in the previous session.
Levels Of Support And Resistance For EBS Stock
The 24-hour chart illustrates a support level at 5.67, which if violated will result in even more drops to 5.23. On the upside, there is a resistance level at 6.40. A further resistance level may holdings at 6.69. The Relative Strength Index (RSI) on the 14-day chart is 71.27, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.38, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 9.60%. Stochastics %K at 67.61% indicates the stock is a holding.
